Real-world data for 21st-century medicine: The clinical and translational science awards program perspective
- PMID: 37830007
- PMCID: PMC10565194
- DOI: 10.1017/cts.2023.588
Real-world data for 21st-century medicine: The clinical and translational science awards program perspective
Conflict of interest statement
This work is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the FDA. The findings, knowledge gaps, challenges and opportunities described in this manuscript represent a summary of individual opinions and ideas expressed during the workshop. The summary does not represent any sort of consensus or directive, nor does it represent an expression of research priorities or intended research directions for NCATS or NIH.
Figures


References
-
- FDA. Real-World Evidence: Food and Drug Administration; 2022. [FDA RWE Definitions and Selected Guidance]. Available from: https://www.fda.gov/science-research/science-and-research-special-topics.... Accessed December 22, 2022.
-
- Concato J, Corrigan-Curay J. Real-world evidence - where are we now? New Engl J Med. 2022;386(18):1680–1682. - PubMed
-
- FDA. FDA Issues Draft Guidances on Real-World Evidence, Prepares to Publish More in Future: Food and Drug Administration; 2022. Available from: https://www.fda.gov/drugs/news-events-human-drugs/fda-issues-draft-guida.... Accessed December 22, 2022.
-
- FDA. Advancing Real-World Evidence Program: Food and Drug Administration 2022. Available from: https://www.fda.gov/drugs/development-resources/advancing-real-world-evi.... Accessed December 22, 2022.
-
- HL7 International. Common Data Models Harmonization - Biomedical Research and Regulation Work Group 2019. Available from: https://build.fhir.org/ig/HL7/cdmh/#guidance-to-the-readers. Accessed December 22, 2022.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources